Profile data is unavailable for this security.
About the company
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
- Revenue in USD (TTM)3.45bn
- Net income in USD79.60m
- Incorporated2000
- Employees11.40k
- LocationBruker Corp40 MANNING RDBILLERICA 01821United StatesUSA
- Phone+1 (978) 663-3660
- Fax+1 (978) 663-5585
- Websitehttps://www.bruker.com/
More ▼
Mergers & acquisitions
| Acquired company | BRKR:NSQ since announced | Transaction value |
|---|---|---|
| Recipe Chemicals Instruments Gmbh | 5.52% | -- |
| Dynamic Biosensors GmbH | -39.26% | -- |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Integer Holdings Corp | 1.75bn | 78.00m | 4.00bn | 11.00k | 53.92 | 2.49 | 20.83 | 2.29 | 2.13 | 2.10 | 49.33 | 46.05 | 0.5445 | 4.87 | 4.94 | 158,744.70 | 2.43 | 3.28 | 2.60 | 3.54 | 27.10 | 26.70 | 4.47 | 6.38 | 2.14 | 4.30 | 0.4396 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| Irhythm Technologies Inc | 618.59m | -98.32m | 4.33bn | 2.00k | -- | 49.99 | -- | 7.01 | -3.14 | -3.14 | 19.74 | 2.72 | 0.6739 | 12.97 | 7.26 | 309,293.50 | -10.71 | -20.12 | -12.08 | -24.37 | 69.39 | 68.61 | -15.89 | -23.90 | 5.58 | -- | 0.8819 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Merit Medical Systems Inc | 1.39bn | 122.26m | 5.00bn | 7.40k | 41.46 | 3.50 | 20.60 | 3.60 | 2.04 | 2.04 | 23.12 | 24.18 | 0.5792 | 2.34 | 7.30 | 187,615.80 | 5.10 | 3.49 | 5.54 | 3.93 | 47.80 | 45.37 | 8.81 | 5.65 | 3.26 | 24.20 | 0.3384 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| Teleflex Inc | 3.01bn | 149.53m | 5.02bn | 14.10k | 35.77 | 1.24 | 11.80 | 1.67 | 3.18 | 3.17 | 64.50 | 91.67 | 0.4112 | 2.10 | 6.59 | 213,485.40 | 2.04 | 4.58 | 2.23 | 5.01 | 55.68 | 54.77 | 4.97 | 11.38 | 1.32 | 7.59 | 0.3178 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Lantheus Holdings Inc | 1.54bn | 254.32m | 5.09bn | 808.00 | 20.89 | 4.37 | 16.06 | 3.31 | 3.52 | 3.52 | 21.62 | 16.84 | 0.7908 | 7.96 | 4.48 | 1,901,855.00 | 13.09 | 9.87 | 14.95 | 11.33 | 64.04 | 60.44 | 16.55 | 12.86 | 5.46 | -- | 0.3275 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| Glaukos Corp | 404.52m | -123.68m | 5.66bn | 995.00 | -- | 7.35 | -- | 13.98 | -2.31 | -2.31 | 7.42 | 13.46 | 0.4259 | 1.79 | 6.85 | 406,555.80 | -13.02 | -11.24 | -14.06 | -12.04 | 75.75 | 73.54 | -30.57 | -36.68 | 5.62 | -- | 0.083 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Guardant Health Inc | 774.00m | -416.55m | 5.86bn | 2.00k | -- | -- | -- | 7.57 | -3.38 | -3.38 | 6.28 | -2.03 | 0.5077 | 4.27 | 7.74 | 387,191.60 | -27.33 | -24.20 | -32.00 | -26.83 | 61.34 | 63.23 | -53.82 | -91.24 | 3.76 | -38.58 | 1.29 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Bruker Corp | 3.45bn | 79.60m | 6.39bn | 11.40k | 80.34 | 3.52 | 22.87 | 1.86 | 0.5252 | 0.5252 | 22.83 | 11.99 | 0.6602 | 1.56 | 5.74 | 302,395.60 | 1.53 | 6.80 | 2.04 | 9.20 | 49.28 | 50.00 | 2.32 | 9.66 | 0.7164 | 13.77 | 0.5331 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Bio Rad Laboratories Inc | 2.54bn | -2.16bn | 6.83bn | 7.70k | -- | 1.03 | -- | 2.69 | -76.20 | -76.20 | 90.48 | 241.72 | 0.2296 | 1.50 | 5.84 | 330,010.40 | -19.55 | 3.00 | -20.45 | 3.15 | 53.68 | 55.37 | -85.17 | 14.51 | 4.43 | 0.1031 | 0.1525 | 0.00 | -3.92 | 2.11 | -189.37 | -- | 13.91 | -- |
| Stevanato Group SpA | 1.30bn | 145.50m | 6.96bn | 5.52k | 47.81 | 4.24 | 29.63 | 5.33 | 0.5332 | 0.5332 | 4.78 | 6.02 | 0.4958 | 2.94 | 2.72 | 236,192.30 | 5.53 | 8.02 | 7.00 | 10.94 | 28.71 | 31.01 | 11.16 | 13.24 | 1.26 | -- | 0.2174 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Repligen Corp | 650.43m | -22.98m | 6.97bn | 1.78k | -- | 3.51 | 99.59 | 10.71 | -0.4124 | -0.4124 | 11.57 | 35.34 | 0.2282 | 1.81 | 4.94 | 365,820.60 | -0.8061 | 3.28 | -0.8557 | 3.70 | 51.15 | 54.24 | -3.53 | 12.37 | 5.79 | -- | 0.2106 | 0.00 | 0.3285 | 18.61 | -171.68 | -- | 5.25 | -- |
| Globus Medical Inc | 2.51bn | 185.56m | 7.79bn | 5.30k | 43.05 | 1.91 | 17.28 | 3.10 | 1.34 | 1.34 | 18.11 | 30.20 | 0.5201 | 1.05 | 4.70 | 473,737.80 | 3.84 | 4.70 | 4.37 | 5.18 | 69.00 | 70.59 | 7.39 | 9.73 | 2.72 | 20.57 | 0.0001 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Masimo Corp | 1.97bn | -276.60m | 8.59bn | 3.60k | -- | 9.07 | -- | 4.35 | -5.17 | -9.21 | 36.51 | 17.46 | 0.7517 | 2.42 | 6.30 | 548,222.30 | -10.54 | 3.29 | -13.17 | 3.99 | 50.50 | 53.94 | -14.02 | 4.56 | 1.62 | 2.12 | 0.4075 | 0.00 | 2.26 | 17.43 | -474.11 | -- | -6.75 | -- |
| Henry Schein Inc | 12.67bn | 407.00m | 8.69bn | 25.00k | 21.60 | 2.57 | 12.46 | 0.6858 | 3.22 | 3.22 | 100.12 | 27.08 | 1.23 | 4.91 | 7.86 | 506,760.00 | 3.88 | 5.43 | 6.38 | 9.19 | 31.60 | 30.23 | 3.16 | 3.98 | 0.7525 | 6.94 | 0.3799 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Caris Life Sciences Inc | 452.50m | -371.16m | 8.70bn | -- | -- | -- | -- | 19.22 | -1.34 | -1.34 | 1.63 | -1.27 | -- | -- | -- | -- | -- | -- | -- | -- | 46.71 | -- | -60.43 | -- | 0.8285 | -4.42 | 16.39 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
Data as of Jul 18 2025. Currency figures normalised to Bruker Corp's reporting currency: US Dollar USD
44.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2025 | 12.38m | 8.17% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 10.37m | 6.84% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 10.20m | 6.73% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2025 | 9.81m | 6.47% |
| Pallas Capital Advisors LLCas of 30 Jun 2025 | 9.50m | 6.27% |
| The London Company of Virginia LLCas of 31 Mar 2025 | 4.14m | 2.73% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 3.83m | 2.53% |
| Sculptor Capital LPas of 31 Mar 2025 | 2.60m | 1.71% |
| Brown Advisory LLCas of 31 Mar 2025 | 2.40m | 1.59% |
| AllianceBernstein LPas of 31 Mar 2025 | 2.39m | 1.58% |
More ▼
Data from 31 Mar 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
